A Study of ARC-02 in B-cell NHL

NCT07691606 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non Hodgkin Lymphoma

Interventions

DRUG: ARC-02
DRUG: Rituximab

Sponsor

Taiho Oncology, Inc.